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Percutaneous t 
emerged as an 
luminal coronary an 
coronary artery disease; its use in patients with multivessel 
disease has resulted in high initial success rates 
incidence of complications (1-9). The long-term 
coronary angioplasty in these patients with multivessel dis- 
ease remains controversial (HI,1 I) and is now the subject of 
several randomized trials. In particular, the consequence of 
incomplete revasculariz has become an important is- 
sue. Previous studies of nts with multivessel disease in 
whom revascularization with either angioplasty (2,4,12,13) 
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or surgery (14-N) was incom ave generally, but not 
always (tg), shown poorer sy atic outcome and sur- 
vival compared with findings in patients in whom complete 
revascularization was achieved. 
Complete revascu~arizatio~ with coronary angio 
may not be achieved in patients with multivessel dise 
a variety of reasons including the presence of an 
occlusion or lesions either unsuitable 
ilate. The iong-term outco 
ted by these and other related v 
ree of revascu~arizat~o~ acbiev 
ous Tra~s~uminai Coronary Angioplasty 
onstrated that differences in ~~~~-terrn 
completely and into pletely revascularize 
multivessel disease could be explained largely 
in baseline patient characteristics (19). 
The purposes ofthis study were to 
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completeness of revascularization on the long-term clinical 
status and need for subsequent i ervention i  a large group 
of patients with multivessel disease who underwent success- 
ful coronary angioplasty, 2) compare baseline characteristics 
of patients with complete and those with incomplete r vas- 
cularization, and 3) determine whether these baseline char- 
acteristics might influence clinical outcome independently 
from revascularization status. 
~otil patient population. Between September 1979 and 
Apt-i! 1988, 1,039 patients with multivessel disease under- 
went coronary angioplasty at the Mayo Clinic. The mean age 
of the 1,039 patients was 62 + 11 years, with 25% aged >70 
years; there were 762 men (73%). The vast majority of 
patients had unstable angina (781 patients, 75%) and 95 
patients (9%) were treated within 24 h of an acute myocardial 
infarction, The mean ejection fraction obtained from ventric- 
ulograms in893 patients was 59 +- 13%; 199 patients (23%) 
had a rest ejection fraction ~50%. 
Patient selection. Eight hundred sixty-seven (83%) of 
these procedures were successful and these patients form 
the basis of this report. All patients had a minimum of 6 
months’ follow-up. Patient selection criteria were based on 
the presence of symptomatic myocardial ischemia poorly 
responsive to medical therapy and suitable coronary anat- 
omy for dilation. Sixty-seven patients (7.7%) underwent 
dilation within 24 h of an acute myocardial infarction but no 
patient in this group had received concomitant thrombolytic 
therapy. 
Coronary stenoses with luminal diameter narrowing 
~70% were considered suitable for dilation if they were 
located in the proximal, mid or distal left anterior descending 
and right coronary arteries, the first or second diagonal 
branches (if 21.5 mm in diameter), the proximal or distal 
circumflex artery or the first and second obtuse marginal 
branches. Angioplasty was performed only if the area of 
myocardium supplied by that vessel was considered to be 
viable, that is, if the area had at least some retained wall 
motion at the time of left ventricular o  radionuclide angiog- 
raphy. The severity of coronary stenoses was visually as- 
sessed by two observers using orthogonal views. 
Most patients were considered potential candidates for 
coronary bypass surgery. The decision to revascularize 
patients with angioplasty rather than with surgical means 
was generally made by the attending physician i consulta- 
tion with the angioplasty personnel and surgeon. Patients 
were not considered for angioplasty if there was significant 
left main coronary artery disease unprotected by bypass 
grafts, multiple chronic total occlusions or severe diffuse 
disease in the vessels to be treated. However, some patients 
who were treated with angioplasty in one or more vessel 
segments had additional disease that was either diffuse or 
distal, or present in vessels considered too small for either 
angioplasty or surgery. In s!;me patients the decision to treat 
with angioplasty rather than surgery was based on the 
presence ofconcomitant severe medical disease, a history of 
prior coronary bypass urgery or the perceived surgical nd 
anesthetic risks. 
Technique. The technique of coronary angioplasty has 
been previously described (20,21). If identilied, the culprit 
lesion was dilated first. Determination f the culprit lesion 
was based on the correlative ofelectroca 
regional ventricular function amd car 
findings. If dilation of this lesion w 
dilation of other significant s enoses was attempted depend- 
ing on the condition of the patient and the preference ofthe 
operator and referring cardiologist. owever, attempts to 
dilate other lesions were not usually made if dilation of the 
culprit lesion had failed. Most patients in whom angioplasty 
failed underwent coronary artery surgery. 
Definitions. Multivessel disease. Multivessel disease was 
defined as ~70% stenosis n one major coronary artery with 
~50% stenosis n one or more other major coronary arteries. 
Two and three vessel disease referred to the number of 
lesions, as defined earlier, present in the distribution ofthe 
left anterior descending, left circumflex and right coronary 
arteries. 
Swcessful angioplusty. Successful angioplasty was de- 
fined as a ~40% reduction ofthe luminal diameter ofat least 
one stenosis without complications requiring coronary ar- 
tery surgery before hospital discharge. 
Completeness of revuscularizntion. Complete revascu- 
larization (group 1) was defined as successful dilation of all 
stenoses 270%. Incomplete r vascularization (group 2) was 
defined as successful dilation of one or more stenoses but 
with one or more residual stenoses ~70%. 
Restenosis. Restenssls on the follow-up angiogram was 
defined as a 230% increase in luminal stenosis over the 
immediate postangioplasty residual stenosis. 
Follow-up. Follow-up was maintained in all patients at 6 
months and then at yearly intervals after their initial proce- 
dure, but data are presented only for those 867 patients with 
successful angioplasty. The follow-up rotocol consisted of 
examining the case records of patients followed up at this 
institution and interviewing all patients by telephone. Doc- 
umentation f follow-up events was sought from physicians 
if the event occurred outside this institution. Angina was 
classified according to the Canadian Heart Association (22), 
and severe angina refers to class III or IV. The subsequent 
need for coronary artery surgery or repeat coronary angio- 
plasty was recorded. Myocardial i~fa~ct~o~ during following 
was assessed from patient records of their home physician or 
the admitting hospital, or both, and was considered tohave 
occurred when two or more of the three following criteria 
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ants was corn 
patients, usually because ve~t~icu~ogra~~y had not been 
performed at the time of diagnostic a~giograpby: to avoid 
excluding these patients from the analysis, each of these 
patients was as an ejection fraction value obtai 
computing the value of the remaining patients 
ever, these data were also categorized in the mod 
separate variable (“ejection fraction not obtai 
the final variables had been identified in the 
pleteness ofrevascularization was entered as a 
adjusting for the variables identified at the p = 0.10 level in 
this model, adjusted survival curves comparing outcomes 
were computed for complete and incomplete r vasculariza- 
tion. A similar analysis was Reformed after uding pa- 
tients without ejection fraction data. All signi ce testing 
using an alpha of 0.05. 
nitial results. Angioplasty was successfully performed in
867 (83%) of the 1,039 patients with multivessel disease. 
Success rates in patients with two and three vessel disease 
were similar: 84% and 83%. respectively. There were 26 
Angina class Gnadian eart Association class i-IV) 
Unstable angina 
New onset angina 
us coronary artery bypass surgery 
us myocardilml infarction 
y of cardiac failure 
Smoking history 
Diabetes 
Hypertension 
~y~ercbo)es~ero~emia (serum cholesterol >250 mgldl) 
Family history of coronary artery disease 
A~~io~~asty within 24 h of acute myocardial infarction 
Angiographic characteristics 
Number of diseased vessels 
aximal stenosis in any vessel 
To:al occlusion 
Proximal left anterior descending stenosis 850% 
Left main stenrisis rSQ% 
Eccentric lesion 3 angioplasly she 
Calcium present in lesion 
emodynamic characleristics 
Ejection fraction (from ve~l~i~~~o~~a~hy~ (%) 
Ejection fraction not obtained 
ing patients in whom 
of acute i~farct~oa, t 
Emergency bypass 
surgery performed during their hospital sta 
de the survivors were contiu~ed on m 
vaseM~a~izati~~ st:W. Complete rev 
achieved in 356 (41%) of the 867 tients with successful 
angioplasty (group I). Five hundre 
despite successful angioplasty in
residual stenosis ~70% in at least one other vessel and were 
thus considered tohave incomplete r vascularization (group 
2). Complete revascularization was achieved in 51% of 540 
patients with two vessel disease c 
patients with three vessel disease 
The most common reasons fo 
~evasc~larization were that, after s 
or more vessels, no attempt was 
a stenosis of 70% to 
patients with incomplete r vascular~zation) or to dilate a 
chronic total occlusion (22.6% of these patients), or both 
(17.9%). Failed attempts at dilation of a vessel lesion Con- 
tributed, in part, to an additional 4.3% of these patients not 
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Table 2. Baseline Clinical, Hemodynamic andAngiographic Data 
of 867 Patients Who Underwent Successful Angioplasty and Who 
Are Compared According to Revascularization Status 
Revascularization Status 
Complete 
(group 1) 
(n = 356) 
Incomplete 
(group 2) 
(n = 511) VLe 
Clinical variables 
Mean age (yr) 
Male gender 
History of diabetes 
History of hypertension 
Current smoker 
Family history of Cn5 
Serum cholesterol >250 mg/dl 
Angina (CHA class III or IV) 
Unstable angina 
Angina of recent onset 
Mean duration of angina (mo.1 
Frior CABG 
Friar infarction 
History of cardiac failure 
FTCA within 24 h of acute 
infarction 
Hemodynamic variable 
Ejection fraction 
(mean + SD) (%I 
Angiographic variables 
Two vessel disease 
Three vessel disease 
Mean maximal stenosis in any 
vessel (%b) 
Mean preangioplasty stenosis of 
lesion (I) 
Total occlusion present 
60? II 63 + 12 
268 (75) 375 (75) 
46 (13) 67 (13) 
148 (42) 272 (53) 
98 (28) I IO (22) 
84 (24) I I5 (23) 
IO1 (28) I58 (31) 
258 (72) 403 (79) 
263 (74) 391 (77) 
155 (44) 176 (34) 
25 46 
28 (8) 109 (21) 
122 (34) 264 (52) 
19 (5) 62 (12) 
15 (4) 52 (IO) 
62 2 12 58 2 13 
275 (77) 
81 (23) 
92 
265 (52) 
246 (48) 
% 
86 89 
43 (12) 280 (55) 
0.001 
NS 
NS 
0.001 
0.04 
NS 
NS 
0.03 
NS 
0.007 
<O.OOl 
co.001 
~0.001 
0.001 
0.001 
<O.OOl 
<O.OOl 
<O.OOl 
<O.OOl 
<o.OOt 
<O.OOl 
Numbers in parentheses are percents. CABG = coronary artery bypass 
grafting; CAD =curonary artery disease: CHA = Canadian Heart Associa- 
tion; FTCA = percutaneous transluminal coronary angioplasty. 
achieving revascularization. O ly 2.8% of patients were 
incompletely revascularized solely because offailed dilation. 
aselle characterIstlcs. The distribution of clinical, he- 
modynamic and angiographic baseline variables for the two 
groups of patients i shown in Table 2. The two groups were 
similar with respect to gender atio and most coronary risk 
factors but there were significant and important differences 
noted in many other characteristics. The presence of class 
III or IV angina was higher in patients in group 2, and they 
were also more likely than patients in group 1 to have had 
prior infarction or coronary artery surgery and to have a 
history of cardiac failure. In addition, 4% of patients ingroup 
1 had angioplasty within 24 h of acute infarction compared 
with 10% in group 2 (p c 0.001) and the ejection fraction at 
baseline was also significantly lower in patients in group 2 
compared with group 1. Significantly more patients in group 
2 than in group 1 had three vessel disease. 
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Follow-up and Sate c
months’ follow-up (mean 2
27 months (range 97) for patients ingroup 1 and of 25 
(range 85) for patients in group 2. The probability o 
free survival for all follow-up cardiac events is shown in 
Figure 1. The probability ofsurvival was only slightly better 
in patients in group 1 versus group 2 (Fig. 1A) (p = 0.051). 
greater occurrence ofsev 
also had a significantly (p = 0 
quent coronary artery bypass 
with patients in group 1, 
was similar (Fig. 1E). However, t
for cardiac event-free survival for any one event, death, 
myocardial infarction or need for coronary artery surgery, 
was higher for patients in group 2 compared with group 1 
(p = 0.091, Fig. IF). 
Factors related to a ulti- 
variate analysis identified several important baseline charac- 
teristics that influenced long-term outcome (Table 3). Once 
these variables had been identified revascu~a~zatio~ 
status included in the model, there no sigoifica~t pre- 
dictive value of completeness of revascularization f r any 
cardiac event either alone or in combination. Adjustment of
ents, with the baseline 
evel) for each individual 
event in the multivariate analysis model showed that the 
differences between patients with complete and those witb 
incomplete revascularization were very much diminished 
(Fig. 2). The small and statistically insignificant differences 
between completely and incompletely revascularized pa- 
tients, noted previously in Figure 1, for death, myocardial 
infarction and repeat angioplasty, become ven smaller after 
this adjustment (Fig. 2A, 2B and 2E). In addition, the 
significant differences previously noted between these pa- 
tients in the occurrence of severe angina, the need for 
subsequent coronary artery surgery and the combined 
events of death, myocardial infarction and need for surgery 
are reduced significantly after accounting for baseline differ- 
ences (Fig. 2C, 2D and 2F). 
The Cox model was also used to identify predictive 
variables for the preceding end points after excluding the 117 
patients in whom no ejection fraction was available. Only 
minor differences from those identified inTable 3 were found 
and, importantly, the additional variable of “completeness 
of revascularization” remained relatively unimportant for all 
these vents: death (p = 0.2228), myocardial infarction (p = 
0.0866). coronary artery bypass urgery (p = 0.0951), severe 
angina (p = 0.6112), repeat angioplasty ( = 0.2523) and for 
death, infarction or coronary surgery (p = 0.0857). 
Restenosis. Within 1 year of angioplasty (mean 4.9 
months), 362 patients (42%) underwent repeat coronary 
JACC Vol. 16. No. 3 
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angiography. Among 159 patients in group I, 93 (58.5%) had 
restenosis documented in at least one dilated coronary 
segment compared with 102 (50%) of 203 
(p = 0.12). 
Coronary angioplasty is being pe with increasing 
frequency in patients with muhives se. The role of 
lasty versus coronary artery bypass surgery 
in this patient population remains undefined, although sev- 
eral randomized studies comparing the two are currently in 
progress. Until the results with extended follow-up of such 
trials are known, careful anaiysis of follow-up data of 
6 
lQ0 
80 
“p.” . . . . . “r”““. 
80 
Q 1 2 3 4 5 6 
iler 
100 
P=O.Qol 
0 
0 1 2 3 4 5 6 
Figure 1. Actuarial event-free survival curves comparing patients 
with complete revascularization (group I) with those with incom- 
plete revascularization (group 2) in terms of freedom from death (A), 
myocardial infarction (MI) ( I. severe angina (Cl. need for coronary 
bypass surgery (CABG) ( ). need for repat angioplasty 
CA) 0% and the combined events of death. myocardial 
infarction and coronary artery bypass surgery l 
patients with ltivessel disease who have 
gioplasty sho continue to provide valuable 
Bn particular, the influence of completeness of revasculariza- 
tion must be considered. C arisons among reported se- 
ries of patients are made d ult by varying de~~itio~s of 
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Myocardial infarction 
CABG 
Severe *ngina (CHA class 111 or IV) 
Repeat PTCA 
Event 
DeathImyocardial infarctiotKABG 
T&M 3. Major Baseline Va&&s in 867 Patients Independently Predictive of Late Cardiac Events 
Revascularization Status 
Revascularization Status Included in 
Regression Model 
Wdictive Variable 
Incomplete revascularization 
History of cardiac failure 
Advanced age 
Hypertension 
Male gender 
Incomplete revascularization 
FICA performed within 24 h of acute infarction 
Maximal lesion stenosis less severe* 
Incomplete revascularization 
PICA performed within 24 h of acute infarction 
prior CABG 
Diabetes 
Ejection fraction obtained+ 
Incomplete revascularization 
Prior CABG 
Advanced CHA class angina 
Advanced age 
Angina not of recent onset 
Serum cholesterol >250 mg/dl 
Incomplete revascularization 
Unstable angina 
Ejection fraction obtained+ 
Younger age 
Incomplete revascularization 
PTCA performed within 24 h of acute infarction 
Diabetes 
Calcium in lesion 
Chronic total occlusion 
Lower ejection fraction 
No 
tp value) 
0.0394 
u.0511 
0.0713 
tt.0853 
0.0033 
0.0091 
0.0199 
0.0230 
<tt.o001 
<0.9901 
0.0098 
0.0293 
0.0343 
0.0078 
0.0374 
0.0437 
- 
0.0902 
0.0179 
0.0186 
0.9433 
0.0491 
Yes 
ip value) 
0.05 16 
0.0483 
0.0812 
0.1079 
0.a22 I 
0.0873 
0.052 
0.0149 
0.0223 
0.0239 
0.6491 
0.0108 
0.0313 
0.0371 
0.2798 
0.0064 
0.0445 
0.0537 
0.1040 
o.aMt2 
0.0213 
0.0139 
0.1845 
0.0613 
*Maximal lesion severity refers to the most severe stenosis observed in any vessel and was considered as a continuous variable from 76% to IftO%: t patients 
who underwent ventriculography from which an ejection fraction was calculated (see text). Abbreviations as in Table 2. 
multivessel disease, angioplasty success and completeness 
of revascularization. 
Immediate outcome. The relatively high success rate for 
coronary angioplasty in patients with multivessel disease 
observed inthis study is similar to those reported by others 
(I-9). The in-hospital mortality rate in our study was 2.5%, 
which is similar to the 2.8% rate reported by Deligonul et al. 
(2) in a similar study of 470 patients but comparatively higher 
than those reported insmaller patient series (1.5.7-9). How- 
ever, many of the patients in our current series were 
considered high risk: 25% were ~70 years old, 75% had 
unstable angina, 9% were treated within 24 h of acute 
myocardial infarction (exclusive of those receiving throm- 
bolytic therapy) and 23% had an ejection fraction ~50%. The 
in-hospital mortality rate was lower (1.7%) after excluding 
those patients in whom angioplasty was used for treatment 
of acute myocardial infarction. 
Completeness of ~V~~M~~ri~~i~~. Surgical experience. 
Completeness of revascularization appears to have an im- 
portant influence on long-term outcome of patients with 
multivessel disease who have undergone coronary artery 
bypass urgery (14-17). The definitions of complete revas- 
cularization vary in these surgical series, but one conclusion 
drawn from these studies i  that complete revascularization 
is associated with improved long-term survival and freedom 
from symptoms including late myocardial infarction. The 
mean follow-up time in these studies ranged from 16 to 46 
months, but with a longer follow-up time the results may be 
different. For example, after a 10 year follow-up of patients 
with two and three vessel disease undergoing coronary 
surgery at the Mayo Clinic, Schaff et a%. (23) 
significant difference insurvival based on revascularization 
status. 
Detailed examination f the influence of baseline varia- 
JAW Vol. 16, No. 3 
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Rsvascularizaticn 
P = NS 
Q 1 2 3 4 5 
YeearS 
bles was not a~tern~ted in these series, although it appeared 
from the study of Tyras et al. (17) that abnormal left 
ventricular function affected survival in a manner similar to 
incomplete revascularizasiion. The presence of a significant 
lesion distal to the graft i~s~~tio~ and the 
occlusion rates of sa~~e~o~s vein grafts 
influence oultcome, and these factors m 
completely and into 
A~~iQpl~~ty exprrimce. The issue of co 
revascularization after successful angioplasty is of major 
interest because complete revascularization has not been 
achieved in the majority of patients with multivessel disease. 
Most studies (2,12,13,18,19) have reported rates of complete 
P= NS 
0 
0 2 3 4 5 6 
IO0 
F 
.- 80 
. . . . . ~..~...~~~~ 
60 
40 
@ 20 
a P = NS 
Q 
0 1 2 3 4 5 
P= 
0 
u 1 2 3 4 5 6 
~j~~re 2. Acluarial event-free survival curves comparing patients 
with complete revascuiarization (group I) with those with incom- 
plete revascularization (group 2) after adjusting for predictive base- 
line variables identified for each event by multivariate analysis. The 
adjusted curves represent event-free survival in :crms of freedom 
from death (A). myocardial infarction (?Gii I ngina K). 
need for coronary artery bypass surgery ( need for 
repeat angioplasty We-PTCAI (El, and the events of 
death, myocardial infarction and coronary artery bypass surgery 
revascolarizaGon of -GO%, although one study (4 reported 
a rate of 77%. In our stu y ordy 41% of successfully treated 
patients bad complete revascularization. Patients with two 
vessel disease were more likely to have complete revascu- 
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larization (51%) than were those with three vessel disease 
(25%), afinding similar to those of two earlier smaller studies 
(2312). 
The most common reason for failure to achieve complete 
revascularization in our study was that, after successful 
angioplasty of one or more lesions, dilation of another 
significant lesion (or lesions) was not attempted. The second 
most frequent cause was the presence of an old total 
occlusion. A strategy of incomplete r vascularization might 
be chosen after identification a d treatment of a so-called 
culprit lesion alone, a priori avoidance of a technically 
difficult or unsuitable sion or the operator’s decision to 
abandon a long or complicated procedure when it is consid- 
ered that the patient’s safety and comfort will be compro- 
mised if dilation of additional lesions is attempted during the 
same procedure, For incomplete r vascularization t  result 
simply because of failed dilation of a second or subsequent 
lesion was distinctly uncommon among our patients. Thus, 
in most cases incomplete r vascularization ca be predicted 
before the procedure and thus can be considered a predeter- 
mined strategy in the majority of patients with multivessel 
disease. A similar observation has been made by Deligonul 
et al. (2). 
Whether the current rates of complete revascularization 
in multivessel disease can be improved with the use of newer 
technology isnot known. For example, attempts orestore 
patency to old total occlusions with current technology have 
met with success rates of only about 59% (26-31) with early 
reocclusion rates as high as 57% (4). However, the effect of 
restored patency of these lesions on long-term outcome 
remains undefined. 
Influence of baseline variables on follow-up events. At first 
this study appears to confirm the findings of others 
(2,4,12,13) that incomplete r vascularization results in lower 
event-free survival compared with complete revasculariza- 
tion. However, this was only true with respect to the need 
for coronary artery bypass urgery and the risk of develop- 
ing severe angina. The probability ofsurvival was marginally 
better for patients with complete revascularization, but this 
did not quite reach statistical significance. The long-term 
probability of myocardial infarction and of repeat angio- 
plasty was similar for both groups. 
However, the definition of completeness of revascular- 
i&on in all these studies was arbitrary and the patients 
analyzed were not randomly assigned to a specific treatment 
group. In the present study notable differences in the base- 
line characteristics of the two groups were identified. Pa- 
tients in whom complete r vascularization was not achieved 
were more likely to be older and to have more severe disease 
(as evidenced by worse angina, longer duration of symp 
tom% higher incidence of three vessel disease and slightly 
greater lesion stenosis severity). They were also more likely 
surgery and have abnormal left ventricular function (with a 
history of cardiac failure and a lower ejection fraction). 
Multivariate analysis identified a number of t 
other variables as predictors of adverse long-term 
that were independent of revascularization statu 
once these variables had been taken into ac 
of revascularization was not strongly p 
long-term cardiac event, and adjusted event-free surviva 
curves demonstra in outcome be- 
tween patients wit te revasc~~a~~za- 
tion could be largely explained by d 
characteristics. 
Reeder et al. (19), in his review of 286 patients with 
multivessel disease from the initial Natio cart, Lung, 
and Blood Institute Percutaneous Transluminal Cororlary 
Angioplasty registry who had undertone successful an 
plasty, also found significant baseline differences between 
patients with complete and incomplete revasc~larizatio~, 
with the latter group of patients being older, with more 
severe angina, lower ejection fraction, a history of prior 
infarction and more eccentric lesions. 
these variables, no dif%erences were fou 
death, myocardial infarction or present 
the two groups. Although the need 
surgery was greater for patients with incomplete r vascular- 
ization, their lower risk for baving repeat angioplasty re- 
sulted in an overall ilar risk of requiring a second 
ite careful analysis of all 
data, this study suffers from the limitations ofany retrospec- 
tive study. Nevertheless, we believe that with the careful 
prospective collection of data and the large population of 
patients it provides meaningful information regarding pa- 
tients with multivessel disease and initially successful angio- 
plasty. Our definition of completeness of revascularization is 
arbitrary and based only on angiographic criteria. The limi- 
tations in the accuracy of visual estimation alone of coronary 
lesions and, more importantly, the inability to detemline the 
physiologic significance of such lesions have been empha- 
sized previously (32,33). 
The multivariate analysis and adjusted event-free survival 
curves utilized a computed mean ejection fraction for pa- 
tients in whom this variable was missing. This presumption 
was made because itwas considered more important ot to 
exclude such a large number of patients from the analysis. 
However, even when the analyses were repeated after 
exclusion of these patients, the lack of a major impact of 
revascularization status on event-free survival was still 
to have had a prior infarction and coronary artery bypass 
evident. Finally, our adjusted event-free survival curves 
were based on a statistical model and, as such, should be 
considered hypothetical; use of different statistical models in 
different patient populations may produce alternative r - 
sults. 
Revascularization status may also be muted by resteno- 
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